Maria Infantino Selected Research

Maria Infantino Research Topics

Disease

19	Rheumatoid Arthritis 01/2022 - 01/2013
12	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2013
8	COVID-19 12/2021 - 01/2020
7	Arthritis (Polyarthritis) 01/2022 - 01/2017
6	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2015
5	Myositis (Idiopathic Inflammatory Myopathies) 10/2022 - 01/2018
5	Psoriatic Arthritis 01/2022 - 04/2016
5	Infections 11/2021 - 04/2016
5	Ankylosing Spondylitis 01/2020 - 01/2017
3	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 03/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2015
3	Muscular Diseases (Myopathy) 01/2021 - 10/2016
3	Necrosis 01/2021 - 01/2013
2	Neoplasms (Cancer) 10/2022 - 03/2020
2	Celiac Disease (Celiac Sprue) 10/2021 - 01/2021
2	Disease Progression 01/2021 - 01/2015
2	Pain (Aches) 01/2021 - 01/2017
2	Hypersensitivity (Allergy) 01/2015 - 01/2013
1	Skin Manifestations 10/2022
1	Dermatomyositis (Dermatopolymyositis) 10/2022
1	Inclusion Body Myositis 10/2022
1	Calcinosis 10/2022
1	Vasculitis (Vasculitides) 01/2022
1	Membranous Glomerulonephritis (Membranous Nephropathy) 04/2021
1	Mood Disorders (Mood Disorder) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Fatigue 01/2021
1	Synovitis 01/2021
1	Pneumonia (Pneumonitis) 11/2020
1	Autoimmune limbic encephalitis 01/2020
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Undifferentiated Connective Tissue Diseases 07/2018
1	Heart Diseases (Heart Disease) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018
1	Ulcerative Colitis 01/2017
1	Crohn Disease (Crohn's Disease) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Myocardial Infarction 10/2016
1	Stroke (Strokes) 10/2016

Drug/Important Bio-Agent (IBA)

25	AntibodiesIBA 10/2022 - 01/2013
10	AutoantibodiesIBA 10/2022 - 10/2016
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2016
5	Biological ProductsIBA 07/2020 - 01/2013
5	tocilizumab (atlizumab)FDA Link 01/2020 - 01/2014
4	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 01/2015
4	Immunoglobulin A (IgA)IBA 10/2021 - 01/2013
4	Immunoglobulin M (IgM)IBA 01/2021 - 01/2013
4	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2020
3	VaccinesIBA 01/2022 - 01/2021
3	Rheumatoid FactorIBA 01/2021 - 09/2014
3	Anti-Citrullinated Protein AntibodiesIBA 01/2021 - 09/2014
3	Immunoglobulin G (IgG)IBA 09/2020 - 01/2015
3	Antirheumatic Agents (DMARD)IBA 07/2020 - 01/2016
3	Abatacept (Orencia)FDA Link 01/2019 - 04/2016
3	Pharmaceutical PreparationsIBA 02/2018 - 01/2016
3	Infliximab (Remicade)FDA Link 01/2018 - 01/2013
2	Ligases (Synthetase)IBA 10/2022 - 01/2018
2	anti-dsDNA autoantibodyIBA 01/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	BNT162 VaccineIBA 01/2022 - 12/2021
2	Neutralizing AntibodiesIBA 01/2022 - 12/2021
2	Rituximab (Mabthera)FDA Link 01/2021 - 08/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 10/2020
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2020 - 10/2016
2	Antinuclear AntibodiesIBA 10/2019 - 01/2019
2	Adalimumab (Humira)FDA Link 01/2018 - 01/2013
2	Etanercept (Enbrel)FDA Link 01/2018 - 01/2013
2	Cartilage Oligomeric Matrix ProteinIBA 02/2015 - 01/2014
1	RNA (Ribonucleic Acid)IBA 10/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	Phospholipase A2 ReceptorsIBA 04/2021
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	TransglutaminasesIBA 01/2021
1	SuspensionsIBA 01/2021
1	SteroidsIBA 01/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2021
1	sarilumabIBA 11/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2020
1	Synthetic DrugsIBA 03/2020
1	ixekizumabIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	golimumab FDA Link 01/2018
1	ElementsIBA 03/2017
1	ImmunosorbentsIBA 01/2017
1	EnzymesIBA 01/2017
1	Biosimilar PharmaceuticalsIBA 01/2017
1	Coenzyme A (CoA)IBA 10/2016
1	Oxidoreductases (Dehydrogenase)IBA 10/2016

Therapy/Procedure

8	Therapeutics 01/2022 - 01/2015
2	Biological Therapy 04/2020 - 04/2016
1	Activities of Daily Living (ADL) 01/2021
1	Self Administration (Administration, Self) 01/2021